Media
The latest news, announcements and media resources
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo library.
Key information
Latest press releases
- GSK welcomes agreement with the Government of Canada for the provision of pandemic and seasonal influenza vaccines
- Regulatory submission for GSK’s daprodustat accepted into Health Canada review
- GSK Canada unveils new head office, embracing a hybrid working model centred around individual and collective performance and personal well-being
- Medicago and GSK announce the approval by Health Canada of COVIFENZ®, an adjuvanted plant-based COVID-19 vaccine
Media contacts
If you are a member of the Canadian media and require more information on GlaxoSmithKline Inc., please contact Corporate Communications at 905-819-3363.
The telephone number above is only for media enquiries. To contact the Mississauga office switchboard, please call 905-819-3000 or visit our Contact Us page.
-
GSK in Canada
GSK has a history in Canada that dates back to 1902
-
Our prescription medicines
Our pharmaceuticals business discovers, develops and makes medicines to treat a broad range of the most common acute and chronic diseases
-
Our vaccines
Our vaccines business develops, produces and distributes around 2 million vaccines every day to people across over 160 countries
